Impact Factor 5.511
2017 JCR, Clarivate Analytics 2018

Among the world's top 10 most-cited Immunology journals

Original Research ARTICLE

Front. Immunol., 14 January 2019 | https://doi.org/10.3389/fimmu.2018.03173

Inhibitory Receptor Crosslinking Quantitatively Dampens Calcium Flux Induced by Activating Receptor Triggering in NK Cells

  • 1Department of Medicine Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden
  • 2Clinical Immunology and Transfusion Medicine, Karolinska University Hospital, Huddinge, Sweden

Natural killer (NK) cell function is regulated by a balance between activating and inhibitory receptors, but the details of this receptor interplay are not extensively understood. We developed a flow cytometry-based assay system in which Ca2+ flux downstream of antibody-mediated activating receptor triggering was studied in the presence or absence of inhibitory receptor co-crosslinking. We show that the inhibitory influence on activating receptor-induced Ca2+ flux is quantitatively regulated, both on murine and human NK cells. Furthermore, both activating and inhibitory receptors operate in an additive way, suggesting that a fine-tuned balance between activating and inhibitory receptors regulate proximal NK cell signaling. We also demonstrate that murine NK cell expression of H2Dd lowered the capacity of Ly49A to deliver inhibitory signals after antibody crosslinking, suggesting that the cis interaction between H2Dd and Ly49A reduce the signaling capacity of Ly49A in this setting. Finally, we show that priming of NK cells by IL-15 rapidly augments Ca2+ flux after activating receptor signaling without attenuating the potential of inhibitory receptors to reduce Ca2+ flux. Our data shed new light on NK cell inhibition and raises new questions for further studies.

Introduction

Natural Killer (NK) cells are innate lymphocytes involved in the immune defense against viral infections and transformed cells (1), and they also exert control over adaptive immune responses (2, 3). NK cells mediate killing of target cells through the secretion of perforin, granzymes and the interaction of Fas-Fas-ligands (4, 5), and they also secrete a multitude of cytokines with immunomodulatory properties (6). The effector functions of NK cells are regulated by signals coming from activating and inhibitory cell surface receptors, which are integrated inside the cells to determine the functional output (7, 8).

In contrast to T cells, each of which possess a unique T cell receptor generated by somatic gene recombination, NK cells express several distinct types of germline-encoded activating receptors that are differentially expressed, signal differently and bind unique ligands on target cells (9). A similar diversity can be found for inhibitory receptors for MHC class I. In mice these belong to the lectin-like Ly49 receptor family, whereas in humans they constitute immunoglobulin superfamily killer immunoglobulin-like receptors (KIR) (10). Both mice and humans also express NKG2A, a lectin-like inhibitory receptor for non-classical MHC class I molecules (11, 12). Ly49 and KIR receptors, respectively, are expressed on overlapping NK cell subsets, in an as yet unexplained manner creating an “NK cell repertoire,” characterized by NK cells expression from zero up to at least 5 inhibitory receptors (13).

During interactions with MHC class I molecules on target cells, inhibitory receptors exert a negative influence on NK cell activation by the recruitment of phosphatases, in particular SHP-1 and SHIP, resulting in diminished NK cell activating receptor signaling (14). The mechanisms underlying NK cell inhibition is complex, but the most studied mechanism involves a de-phosphorylation event acting on the intracellular signaling mediator VAV, which act downstream of activating NK cell receptors (15, 16). Furthermore, a recent study showed that inhibitory receptor engagement increased ubiquitilation of LAT, suggesting that inhibitory receptor signaling may also function by limiting the availability of signaling substrates inside the NK cells (17).

Given the central role for inhibitory receptors in NK cell function, surprisingly little is known about the nature of the activating and inhibitory signal cross-talk in NK cells. It is assumed that intracellular signals transduced by the triggering of activating and inhibitory receptors are integrated through a cross-talk proximal to the cell membrane (8, 17, 18), but this cross-talk has not been studied in much detail. In addition, while it is suggested that NK cell activation is controlled by a threshold of activation (19), it is not clear whether a signaling threshold can be measured experimentally at the level of early Ca2+ flux. Furthermore, whether or not the inhibitory signals are binary (all or none) or dynamic and quantitative, if they are affected by the cis interaction with MHC class I or if they are influenced by cytokines that regulate NK cell function, such as IL-15, are remaining questions.

We developed an assay to measure the inhibitory influence by Ly49 or NKG2A receptors on murine NK cell activation and by the NKG2A receptor on human NK cells, read out as the inhibition of Ca2+ flux after co-crosslinking of activating receptors. Intracellular Ca2+ fluxes correlate with NK cell effector functions, including degranulation and cytokine production (20). Using this assay, we provide several novel insights of relevance to the way by which inhibitory receptors may control NK cell function.

Results

Activating Receptor Crosslinking Quantitatively and Additively Modulates Ca2+ Flux in Primary Mouse NK Cells

It has been demonstrated that inhibitory receptor ligation exert proximal down-modulatory effects on signaling pathways downstream of activating receptors, but the nature of these inhibitory influences have not been extensively studied. To gain further insight into this process, we established an in vitro system based on co-crosslinking of activating and inhibitory NK cell receptors on mouse and human NK cells, followed by a FACS-based assay for Ca2+ flux in real time (Figure S1). We reasoned that this setup would allow us to investigate if inhibitory receptor triggering quantitatively downregulates NK cell activation, or if inhibition would operate in a threshold mode.

In a first step, we identified reagents that could be used to identify subsets of mouse NK cells and at the same time be used to cross-link activating and inhibitory receptors simultaneously (Table S1). Following crosslinking of NK1.1-APC-stained NK cells using a F(ab)2 fragment of a goat-anti-mouse secondary antibody, a flux of Ca2+ characterized by a rapid onset, a peak and a relaxation phase was recorded in real-time using a ratiometric flow cytometry method based on Fluo-4 and Fura-Red staining (Figures 1A,B; see Materials and Methods). Crosslinking the activating receptor NKp46 also elicited a rapid Ca2+ flux response in mouse NK cells (Figures 1C,D), but with different kinetics characterized by a slower onset compared to NK1.1. For both NK1.1 and NKp46 stimulation, the extent of Ca2+ flux was sensitive to the amount of primary antibody in all experiments, at least for the concentrations of crosslinking antibodies we used (Figures 1B,D). In line with a quantitative response to signaling strength, when these two activating receptors were co-crosslinked, NK cells displayed an additive enhanced calcium flux response, with both earlier onset and higher peak value in NK cell crosslinked via the two receptors simultaneously (Figures 1E,F).

FIGURE 1
www.frontiersin.org

Figure 1. Induction of Ca2+ flux in mouse NK cells after crosslinking of activating receptors. (A) Calcium flux response (kinetics plot of the ratio between Fluo-4 and Fura-red) after NK1.1 crosslinking. The colored lines depict various concentrations of the primary antibody.One representative experiment. (B) Total area-under-the-curve (AUC) values after baseline correction (see Materials and Methods) from four independent experiments. Different colors indicate different experiments. Statistics calculated using a one-way paired Student's T-test. (C) Same setup as in A but with an antibody against NKp46. (D) Same setup as in (B) but for NKp46 antibody. (E) Calciums flux response (kinetics plot of the between Flou-4 and Fura-red) after individual and simultaneous crosslinking of NK1.1 and NKp46 on isolated NK cells. Different crosslinkers were used for NK11 and NKp46 primary antibodies. DARLC, donkey-anti-rat (used for NKp46) and GAMCL, goat-anti-mouse (used for NK1.1). One representative experiment. Note lack of cross-reactivity beteen the crosslinkers (flat lines). (F) Total AUC values after baseline correction (see Material and Methods) from 5 to 7 independent experiments, which are color-coded. Some experiments did not inluce all groups. Note additive Ca2+ flux response when two receptors were crosslinked simultaneously. Statistical analysis was performed using a one-way ANOVA with Tukey's multiple comparisons test. *p < 0.05, **p< 0.01, ***p< 0.001, ns, not significant.

Inhibitory Receptor Crosslinking Quantitively and Additively Downregulates Activating Signals in Primary Mouse NK Cells

We next tested if co-crosslinking NK1.1 and NKp46 receptors with inhibitory Ly49 or NKG2A receptors simultaneously would dampen Ca2+ flux triggered by the activating receptors, which would support a proximal influence on early NK cell signaling. To test this, we designed a co-staining protocol in which NK cells were double-stained with antibodies against activating receptors NK1.1 or NKp46 and antibodies against either Ly49A, Ly49G2, or NKG2A, with the aim of co-crosslinking these antibodies using an IgG F(ab)2 fragment with specificity for both activating and inhibitory antibodies. In order for this setup to work as intended, it was necessary to make sure that flourochrome-labeled primary antibodies against inhibitory receptors could be used (Figure S1). Because all inhibitory receptors in the mouse are expressed on subsets of NK cells, this setup would allow detection of a control subset and a test subset in the same sample, providing a critical test if inhibitory receptor triggering quantitatively downregulates NK cell triggering, or if it operates by means of a threshold effect.

When applying this setup for Ly49A, Ly49G2, and NKG2A, we confirmed our previous data (21), showing that these receptors were all capable of downregulating Ca2+ flux triggered by NK1.1 simulation (Figure 2A, left). Two of the inhibitory receptors, Ly49A and Ly49G2 were also tested in conjunction with NKp46, with similar outcome (Figure 2A, right). By titrating the amount of antibody against the inhibitory receptors, we established that both Ly49A and Ly49G2 crosslinking downregulated ITAM-dependent NK1.1 and NKp46 triggering in a dose-dependent way, suggesting that the inhibitory receptor activity, at least in this setup, was able to quantitatively inhibit Ca2+ flux downstream of activating receptor ligation (Figures 2B–G). NKG2A was not possible to use in these titration experiments, since staining was rapidly lost after titration and the cells could not be identified clearly using lower concentrations than 1:50.

FIGURE 2
www.frontiersin.org

Figure 2. Inhibitory receptor (IR) crosslinking quantitatively downmodulates Ca2+ flux induced by activating receptor stimulation. (A) Top: Staining of Ly49A, Ly49G2 and NKG2A on mouse NK cells. Bottom: Kinetics plot of Fluo-4 fluorescence after crosslinking of NK cells coated with antibodies against NK1.1 (left) and NKp46 (right) in the presence of antibodies against inhibitory receptors Ly49A, Ly49G2 and NKG2A as indicated. Red line represents the response on the NK cell subset expressing the inhibitory receptor in question and the blue line represents the inhibitory receptor-negative subset in the same sample. Gates were set on plots in the top panel. Corresponding concentrations of the antibodies in the various dilutions are indicated in Table S1. (B) Reduction of inhibitory influence on activating signals after titration of inibitory antibody. Top: staining of Ly49G2 at various antibody dilutions. Bottom: Kinetics plot of Fluo-4 fluorescence after NK1.1 activation in the presence of various concentrations of Ly49G2. Red line represents the response on the NK cell subset expressing the inhibitory receptor in question and the blue line represents the inhibitory receptor-negative subset in the same sample. (C) The “inhibition index” (see Materials and Methods) becomes bigger following reduced concentration of inhibitory recept antibody. Data from four individual color-coded experiments. The red experiments is the one depicted in (B). (D) Statistical analysis between the 1:400 and 1:1600 groups in (C) using Student's T-test. (E–G) Same setups as in (B–D) but for Ly49A instead. (H) Double staining of Ly49A and Ly49G2 on isolated mouse NK cells. Dilutions of the antibodies was chosen so as to provide clearly detectable stainings an at the same time only partial inhibition. (I) Kinetics plot of the Fluo-4/Fura-red flourescence ratio in NK cells expressing Ly49A, Ly49G2, both receptors or none of these receptors. (J) Statistical analysis of the AUC values after baseline correction of Ca2+ flux from the three subsets expressing either one or both inhibitory receptors in I. Summary of 5 independent experiments, which are color-coded. The red experiment is shown in (I). Statistical analysis in (D,G) was performed using a two-way Student's T test and in (J) using a one-way ANOVA with Tukey's multiple comparisons test. *p < 0.05, **p < 0.01, ns, not significant.

NK cells express combinations of inhibitory receptors, some of which may be specific for the same MHC class I allele (13). Thus, it was of interest to ask if two different inhibitory receptors would co-operate for inhibition of ITAM signaling, which was previously suggested in assays of NK cell cytotoxicity (7). To test this, we stained NK cells with antibodies against NKp46, Ly49A, and Ly49G2 (all three being rat antibodies), and added donkey-anti-rat F(Ab)2 fragments for crosslinking. By gating on NK cells based on either one or both inhibitory receptors (Figure 2H), we asked if crosslinking of two receptors would inhibit Ca2+ flux more efficiently than co-crosslinking of only one inhibitory receptor? Our experiment with this setup demonstrated that NK cell expressing both inhibitory receptors indeed showed less Ca2+ flux compared to NK cells expressing only one inhibitory receptor (Figures 2I,J), suggesting that two inhibitory receptors co-operate in limiting proximal NK cell signaling downstream of ITAM signaling.

The Inhibitory Effect of Ly49A, but Not Ly49G2, Is Reduced by Expression of H2Dd at the Cell Surface of the Ly49A+ NK Cell

Several studies have reported that the Ly49A receptor binds its ligand H2Dd both in cis, i.e., on the same cell, and in trans, i.e., when the ligand is expressed by surrounding cells. This binding is mediated by the same interaction site and the two modes of binding appear to be mutually exclusive (22, 23). Thus, cis interaction with H2Dd restricts access of the Ly49A receptor to H2Dd presented in trans, e.g., in the form of H2Dd tetramers (24). To provide further insight into the inhibitory function of the Ly49A receptor on NK cells expressing H2Dd, we performed crosslinking experiments of Ly49A on NK cells from mice expressing H2Dd as a single MHC class I molecule and compared the results with crosslinking of Ly49A on NK cells from B6 mice, which lack H2Dd. Despite the fact that Ly49A+ NK cells are more functional in H2Dd mice compared to B6 mice (25), no inhibitory function of Ly49A was seen at any antibody concentrations that were tested (Figure 3A). In contrast, even the lowest dilution of anti-Ly49A antibody tested (1:6,400) yielded strong inhibition of B6 NK cells in this series of experiments (Figure 3B).

FIGURE 3
www.frontiersin.org

Figure 3. Poor effect of Ly49A receptor crosslinking on NK1.1-induced Ca2+ flux in NK cells from mice expressing the Ly49A ligand H2Dd. (A) Top: Staining of Ly49A on NKp46+ NK cells from H2Dd mice at various dilutions of anti-Ly49A antibodies. Bottom: Kinetics plot of the Fluo-4/Fura-red flourescence ratios in NK cells from H2Dd mice stained with various concentrations of anti-Ly49A together with a fixed concentration of anti-NK1.1. The blue line represents the response of the NK cell subset expressing Ly49A and the red line represents Ly49A-negative NK cells in the same sample. (B) Same setup as in A but on NK cells from B6 mice. (C) Mean fluorescence intensity (MFI) of Ly49A staining at various dilutions of anti-Ly49A on NK cells derived from B6 (black bars) or H2Dd (white bars) mice. Three independent experiments are pooled. Arrows indicate antibody titrations at which the MFI of Ly49A staining was similar between B6 and H2Dd mice. (D) AUC values of Ca2+ flux in Ly49A-positive and Ly49A-negative NK cells from B6 and H2Dd mice at the anti-Ly49A concentrations indicated by arrows in (C) (1:100 for H2Dd and 1:3,200 for B6). Statistical analysis performed using one-way ANOVA with Tukey's multiple comparisons test. (E) Top: Staining of Ly49G2 on NKp46+ cells from H2Dd mice. Bottom: Kinetics plot of the Fluo-4/Fura-red flourescence ratios in Ly49G2-positive (blue) and Ly49G2-negative (red) NK cells from H2Dd mice stained with anti-Ly49G2 at 1:400 dilution. (F) Inhibition index comparison between the degree of Ly49G2-mediated inhibition in H2Dd mice and B6 mice. Based on 3–4 independent and comparable experiments. Statistics was calculated using a paired Student's T-test. *p < 0.05, ns , not significant.

The cis interaction with H2Dd restricts cell surface expression of Ly49A by a combination of Ly49A internalization and antibody epitope blocking (26). It was therefore possible that the lack of inhibition of Ly49A+ NK cells from H2Dd mice was the result of lower amounts of Ly49A antibody at the surface of H2Dd+ NK cells compared to B6 NK cells. To control for this, we performed a parallel titration of antibody staining on H2Dd mice and B6 mice and related the inhibitory capacity of the antibody to the cell surface staining intensity. When we compared samples from B6 and H2Dd mice that showed the same intensity of anti-Ly49A staining, 1:3,200 in B6 vs. 1:100 in H2Dd mice (Figure 3C), we found a clear inhibitory effect on B6 NK cells but no inhibition at all on H2Dd NK cells (Figure 3D), supporting a qualitatively different role of the Ly49A receptor to transmit inhibitory signals in the presence of the ligand expressed in the same cell membrane.

To test if the lack of inhibitory function was unique to the Ly49A receptor, we crosslinked the Ly49G2 receptor on H2Dd and B6 NK cells and observed clear inhibition of Ca2+ flux on both H2Dd and B6 NK cells (Figures 3E,F). Thus, on H2Dd NK cells, the poor accessibility and poor signaling capacity seems unique to the Ly49A receptor and does not apply to the Ly49G2 receptor, which is consistent with poor ability of Ly49A to bind H2Dd in trans (26). These data suggest that the cis interaction not only restricts binding, but also the ability of the receptor to deliver inhibitory signals into the cell after antibody-mediated crosslinking at the cell surface.

NK Cell Priming by IL-15 Does Not Influence the Inhibitory Capacity of Ly49 Receptors

Stimulation with the cytokine IL-15 “primes” NK cells, resulting in a more efficient and more rapid response to activation (27, 28). The mechanisms underlying NK cell priming are not known in detail, but seem to involve an augmentation of the AKT-mTOR axis of NK cell signaling (2931). Because the purpose of NK cell priming would be to enhance NK cell responsiveness, it was of interest to ask if the capacity for NK cell inhibition would be reduced, or even abrogated, by IL-15-priming. To determine if our experimental system could be used to test this question, we first investigated the Ca2+ flux response to NK1.1 triggering in IL-15-primed and non-primed NK cells. A 2-h incubation with IL-15 enhanced NK1.1-triggered Ca2+ responses (Figures 4A,B, compare blue and green lines) indicating that IL-15 potentiates ITAM signaling downstream of NK1.1.

FIGURE 4
www.frontiersin.org

Figure 4. IL-15 priming does not abrogate the capacity of inhibitory receptor crosslinking to dampen Ca2+ flux in B6 NK cells. (A) One representative experiment showing kinetics of Fluo-4 fluorescence in Ly49A+ and Ly49A IL-15-primed or non-primed NK cells. (B) Same as in (A) but gated on Ly49G2+ NK cells. (C) Top: Total AUC values after baseline correction of Ly49A and Ly49A+ NK cells with or without IL-15 from 6 independent experiments. Lines connect subsets from the same experiment. Bottom: Inhibition index for anti-Ly49A crosslinking in IL-15-primed and non-primed NK cells. (D) Same setup as as in (C) but for Ly49G2+ NK cells. ns , not significant.

When NK1.1 was co-crosslinked with either Ly49A or Ly49G2, we found that IL-15 priming induced Ca2+ flux also in the Ly49A+ and Ly49G2+ NK cell subsets (Figures 4A,B, compare red and black lines), and that the efficiency of the inhibitory receptor to shut off NK1.1-triggered Ca2+ release seemed to be unaffected (Figures 4A,B). Quantification of this response in a larger series of experiments substantiated this conclusion, and showed that the efficiency of inhibitory signaling downstream of Ly49A and Ly49G2 was equally efficient on IL-15-primed and non-primed NK cells (Figures 4C,D).

NKG2A Co-crosslinking Quantitatively, but Variably, Dampens NKp46-Triggered Ca2+ Flux in NK Cells From 6 Human Donors

We next investigated if inhibitory signaling also dampened Ca2+ flux downstream of activating receptors in human NK cells. Here, we focused on the NKG2A receptor and used streptavidin to co-crosslink biotinylated antibodies against NKp46 and CD94, using fluorescent antibodies against NKG2A and NKG2C to distinguish these subsets (Figures S2, S3; Table S2). Quantitative inhibition of NKp46-induced Ca2+ flux was observed in all 6 donors, albeit with varying efficiency between donors (Figure 5A). Because the CD57 marker was included in the staining protocol (Figure S2) we were able to extend the analysis in human NK cells by gating on this marker, which is frequently used to identify mature NK cells in humans (32). In a first step, we quantified the extent of inhibition on CD57 low NK cells in each donor by calculating the AUC for for each concentration of anti-CD94 antibody. This analysis demonstrated a similar titration curve for each donor, characterized by an early linear drop of varying degree followed by a plateau as the concentreation of anti-CD94 reached 0.5 μg/ml (Figure 5B). Fractions of CD57high NK cells varied between the donors (Figure 5C). When we repeated the same analysis on CD57high NK cells, we found a similar pattern of titration (Figure 5D) but with generally higher AUC values (Figure 5D). When the Ca2+ flux after NKp46 crosslinking (in the absence of inhibition) was compared, we found that CD57high NK cells showed a statistically verified stronger Ca2+ flux response compared to CD57low NK cells (Figure 5E), suggesting an intrinsically increased responsiveness of the CD57high subset. However, despite this, the inhibitory effect of anti-CD94 crosslinking on NKG2A+ NK cells titrated in a similar way in CD57low and CD57high NK cells (Figure 5F), arguing that despite higher responsiveness to activating receptor crosslinking in CD57high NK cells (Figure 5E), the inhibitory capacity of NKG2A was the same (Figure 5F).

FIGURE 5
www.frontiersin.org

Figure 5. Crosslinking of NKG2A dampens Ca2+ flux triggered by NKp46 stimulation in human 6 human donors. (A) Kinetics plot of Fluo-8 fluorescence of CD57 low, CD56+, NKG2A+ NK cells stained with biotinylated anti-NKp46 and biotinylated anti-CD94 and co-crosslinked using by Streptavidin. HD1-HD6 depict the 6 donors. Different concentrations of anti-NKG2A are color-coded. (B,D) Total AUC values of CD56+ NKG2A+ CD57 low NK cells, after baseline correction, of the data in (A). Statistics were calculated using a paired Student's T-test for the combinations indicated. (C) The fractions of CD57high/CD57low NK cells from HD1-HD6. Gating as indicaed in Figure S2. (D) Similar data as in (B) but for CD56+ NKG2A+ CD57 high NK cells. (E) Total AUC values of CD57 high and CD57 low NK cells stimulated with biotinylated anti-NKp46 and crosslinked with Streptavidin, in the absence of inhibitory receptor crosslinking. Statistics were calculated using a parid Student's T-test. (F) The inhibition index obtained by streptavidin-mediated crosslinking of NKG2A+ NK cells at lowering concentration of biotinylated anti-CD94, and comparing CD57 low and CD57 high NK cells. No significant differences were seen. *p < 0.05, **p < 0.01, ****p < 0.0001, ns, not significant.

Discussion

We here report that co-crosslinking activating and inhibitory receptors using antibodies resulted in downregulation of Ca2+ flux in both mouse and human NK cells in a manner that was sensitive to the amount of added crosslinker against the inhibitory receptor. Similarly, in humans, inhibitory capacity of NKG2A also titrated with the antibody concentration, was variable between donors but independent from the expression of CD57. We also show that activating and inhibitory receptors of different types operated additively, suggesting that they can co-operate in regulating NK cell activity when NK cells meet target with several types of ligands for activating and inhibitory receptors. In the mouse, the inhibitory signaling capacity of the Ly49A receptor was impaired by the presence of H2Dd in the same cell, suggesting that the cis interaction between H2Dd and Ly49A impairs the ability of Ly49A to transmit inhibitory signals after antibody crosslinking. Furthermore, 2 h of IL-15 priming of NK cells augmented Ca2+ signaling downstream of the activating receptor NK1.1. Nonetheless, the inhibitory receptor signaling capacity was not changed following IL-15 stimulation. Thus, our assay for inhibitory receptor activity, in which Ca2+ release could be studied in inhibitory receptor-positive NK cells in the same sample, has revealed features of inhibitory receptor function that was not previously well characterized.

It is well established that inhibitory receptors are sensitive to different amount of target cell MHC class I, both during NK cell killing (19) and during NK cell education (3336). To our knowledge, our data is the first, however, to demonstrate that inhibitory receptor signaling quantitatively downmodulates activating receptor signaling toward Ca2+ flux, most compellingly demonstrated by the successive decrease in Ca2+ flux after NK1.1 or NKp46 receptor co-crosslinking in the presence of increasing amount of antibody, or streptavidin, against inhibitory receptors in two different species. An alternative to this result would have been a threshold of inhibition, which was implied from previous work on NK cell cytotoxicity against target cells transfected with different amount of HLA class I ligands (19). In such a model, inhibition of signaling would require a certain amount of SHP-1 to be recruited to the immune synapse to accumulate close to the activating receptor signaling complex, before a cascade of de-phosphorylation is initiated. Our data argue against such a model and instead suggests a fine-tuned regulation, in which small perturbations in the balance between kinases and phosphatases modulate the threshold of activation for individual NK cells, both in humans and in mice, in real time (37). However, it is likely that the regulation of effector functions such as cytotoxicity or cytokine release are subject to more complex regulation downstream of Ca2+ flux, e.g., regulating gene transcription, cellular polarization and granule release necessary for their execution. Activation thresholds may be set at such levels, in a process by which a linear signaling stream triggered by receptor ligation might be translated into a threshold switch more downstream. Testing such a model would require novel types of analysis systems in which effects of inhibitory receptor ligation downstream of Ca2+ flux could be evaluated in real time, something which attains significant technical challenges due to the time delays between initial triggering and e.g., granule release.

Some Ly49 receptors, of which Ly49A is the most studied, interact with its MHC class I ligand in cis, i.e., in the same cell membrane (23, 26, 38, 39). This property impacts in many ways on Ly49A receptor biology, the most significant of which is a conformational change in the Ly49A receptor structure into a bent conformation that protects H2Dd binding sites for both antibodies and for H2Dd tetramers (2224). In support of this notion, we found limited access of Ly49A on H2Dd-expressing NK cells to conformation-specific antibodies in this paper. In addition, we were completely unable to observe any negative impact after co-crosslinking Ly49A with NK1.1 on NK cell expressing H2Dd, which was in contrast to crosslinking Ly49A on H2Dd-negative NK cells, in which binding of anti-Ly49A antibodies (titrated to the same extent as in the H2Dd-positive NK cells) provided inhibitory input. This surprising finding raises questions regarding one of the basic tenets of “missing self” recognition, which is that self-tolerance is determined, at the level of the individual NK cell, by inhibitory interactions between Ly49 receptors and self MHC class I on surrounding cells (40). This would be considered particularly important in NK cells expressing Ly49A in H2Dd mice, in which Ly49A-expressing NK cell subsets are the most efficiently educated subsets with the best functional capacity (25). It is important to note, however, that our data does not imply that the Ly49A receptor complexed in cis with H2Dd is completely unable to provide inhibitory input from H2Dd expressed on other cells. Binding of Ly49A to its “real” ligand H2Dd on target cells during effector target interactions, might lead to competition between external and internal H2Dd that could liberate Ly49A epitopes for H2Dd binding on other cells. Arguing against this, on the other hand, is the finding that the switch between cis and trans conformation of Ly49A is predicted to be energetically unfavorable (22). In the end, this question must be tested experimentally by isolating NK cells from H2Dd mice expressing only Ly49A and subject them to lysis of target cells expressing H2Dd. So far, our system, which measures inhibitory input from single Ly49 receptors, nevertheless implies that the cis interaction severely limits the capacity of Ly49A to transmit negative signals to NK cells.

One additional point should be made in conjunction with this discussion. We did, reproducibly, find that lowering the anti-Ly49A concentration paradoxically increased Ca2+ flux in Ly49A+ NK cells in H2Dd mice while at the same time leaving Ca2+ flux in Ly49A- NK cell unaffected. We think this finding reflects the higher responsiveness of Ly49A+ vs. Ly49A- NK cells in H2Dd mice (25, 41), which becomes apparent as the anti-Ly49A antibody is diluted and loses its inhibitory potential, yet remains visible for detection of Ly49A+ NK cells using FACS. If this interpretation is correct, it suggests that anti-Ly49A antibodies are capable of triggering some degree of inhibition of Ly49A+ NK cells from H2Dd mice, when applied at very high concentrations.

The cytokine IL-15 plays a pleiotropic role in NK cell biology, including being a priming factor for NK cell functional capacity (2729). The priming effect of IL-15 is manifested as an augmentation of functional responses, such as killing and cytokine secretion, as a result from a short incubation time before NK cell function is triggered. Given this apparent direct impact on ITAM-dependent NK cell signaling, it was of interest to evaluate if part of the priming response could involve effects on the inhibitory signaling pathways, perhaps manifested as a reduced inhibitory effect of a given inhibitory receptor trigger. Our data did not support such a role but suggest that IL-15 priming is in direct balance with Ly49 receptor triggering and that no specific impact on the inhibitory receptor signaling components was revealed. A conclusion of the same type could be made when comparing CD57high and CD57low NK cells in human NK cells, which suggest that NK cells displaying an intrinsically higher responsiveness were similarly sensitive to inhibitory signals. Taken together, these data thus propose that the responsiveness of NK cells, dictated by the intrinsic capacity of activating signaling pathways determined e.g., by maturation or priming, do not influence the degree of inhibition by a given inhibitory stimulus.

In summary, our study provide evidence to suggest that inhibitory Ly49 and NKG2A receptors downregulate Ca2+ flux downstream of ITAM signaling in a linear way, following co-crosslinking of activating and inhibitory receptors on both human and murine NK cells. Furthermore, our data imply that the cis interaction between Ly49A and H2Dd strongly reduces the capacity of Ly49A to transmit negative signals after crosslinking and that short-term IL-15 priming operates independently from inhibitory receptor signaling. New experiments will be required to elucidate the molecular basis for these findings.

Materials and Methods

Mice

C57Bl/6 (B6) mice were purchased from Jackson laboratory and were used at 6–10 weeks of age. Mice transgenic for H2Dd (and lacking H2b molecules) were previously described (25, 41) and were bred and maintained in the animal facility at Karolinska Institutet, Huddinge. Breedings and animal handling followed institutional guidelines at Karolinska Institutet and at the Karolinska University Hospital. All experimental procedures were approved by the Stockholm branch of the regional animal ethics committee in Sweden (Stockholm Södra Djurförsöksetiska Nämnd and Linköpings Djurförsöksetiska Nämnd).

Antibodies and Flow Cytometry Analysis

All antibodies and their concentrations used in this study are detailed in Tables S1, S2. For flow cytometry, single cell suspension of mouse splenocytes were incubated with anti-FcyRIII (2.4G2) for 20 min before staining with antibodies agains specific surface markers. Stainings were performed at 4°C in HBSS supplemented with 1% FCS for 20 min. Dead cells were excluded using LIVE/DEAD® Fixable Aqua Dead Cell Stain Kit (Invitrogen). Acquisition of flow cytometry data was done using the LSR Fortessa instrument (BD Biosciences) or the LSR Symphony instrument (BD Biosciences). Data analysis was done by FlowJo 9.9.4 (Tree Star).

NK Cell Analysis of Ca2+ Flux

Mouse NK cells were isolated from spleen using a negative selection kit for NK cell isolation (Miltenyi Biotec), which results in a NK cell purity of >90%. Purified NK cells were subsequently incubated with antibodies against cell surface receptors. After antibody staining, NK cells were stained for 20 min at 4°C in HBSS + 1% FCS and probenecid with calcium dyes Fluo-4 and Fura-red (Life Technologies). Cells were then kept on ice until analysis.

Primary human NK cells were purified from peripheral blood mononuclear cells (PBMC) from healthy volunteers by a similar negative isolation procedure as for mouse cells, according to the manufacturer's instructions (Miltenyi Biotec). Human NK cells were rested overnight in RPMI1640 (Gibco) supplemented with 10% fetal calf serum (Sigma-Aldrich) in a humidified incubator at 37°C and 5% CO2 (v/v). A viability check for 90–95% live cells was performed by a counter. Rested NK cells were washed once with assay buffer (HBSS supplemented with 1 mM probenecid (Gibco and ThermoFisher) and one million cells per condition transferred to a 96-well V-bottom plate (Sarstedt). Cells were then simultaneously labeled with fluorochrome conjugated and indicated concentrations of biotinylated monoclonal antibodies as well as loaded with 1 μM of the calcium indicator Fluo-8 a.m. (Abcam) in assay buffer for 1 h on ice. Afterwards, cells were washed, resuspended in cold assay buffer and kept on ice until acquisition on an LSR II Fortessa (BD Biosciences).

To record Ca2+ flux, tubes were pre-warmed at 37°C in a water bath for 10 min after which a baseline fluorescence signal was acquired for 30 s. Following this period, the tube was removed from the cytometer and a crosslinker was added. For mouse NK cells, 6 μl of polyclonal purified Goat-anti-Mouse IgG or Donkey-anti-Rat IgG (Jackson Immunoresearch), both at 1,3 mg/ml, was added to a final concentration of 20 μg/ml. For human NK cells, 1 μg of streptavidin was added, to a final concentration of 3 μg/ml to induce cross-linking of biotinylated antibodies. After the addition of crosslinker, acquisition was continued for an additional 210 s (humans) or 300 s (mouse). For human experiments and some mouse experiments, Fluo-4 (B-530-A) of Fluo-8 alone was used to record calcium flux. For some mouse experiments, both Fluo-4 (B-530-A) and Fura-red (B-710-A) were used and a ratiometric analyis (B-530-A/B-710-A) was applied during analysis.

Analysis of Ca2+ Flux Data

To quantify receptor-induced iCa2+ mobilization, we used the kinetics analysis in the FlowJo analysis software (BD Biosciences) to determine the area under the curve (AUC) of each calcium flux plot. To allow for inter-experimental comparison, we used the kinetics algorithm in FlowJo to divide each calcium plot into 16 arbitrary regions and determined the AUC for each of those. When 16 regions were used, the first 2 always defined the time before addition of crosslinker. This allowed us to use the mean AUC value from these two regions as background flourescence, which was subsequently subtracted from the AUC value of each of the remaining regions, allowing the creation of an AUC curve reflecting the specific enhancing effect of the crosslinker relative to the background for each plot. In doing so, inter-experimental variation was reduced and a combined analysis between experiments became feasible. Region 3, encompassing the gap in the curve resulting from removal of the tube for addition of crosslinker, was excluded from the analysis. AUC values were exported from FlowJo into MS-Excel where calculations were performed.

Inhibitory Receptor Crosslinking and Effect on Ca2+ Flux

To measure the influence of inhibitory crosslinking on activating receptor signaling, purified NK cells were stained with fluorescently labeled antibodies against inhibitory receptors together with a live/dead stain, a flourescently tagged detection antibody for NK cells (to which the crosslinker did not bind), Fluo-4/Fura-red and a triggering antibody for NK cells. Analysis of Ca2+ flux was performed as described above in the previous sections. During analysis, inhibitory receptor-positive and negative NK cells were separately gated based on their flourescence and analyzed with kinetics parameter for ratio (Fluo-4/Fura-red) and AUC (Area Under the Curves) as described in the previous sections. For some summary experments (e.g., in Figure 2) an “inhibition index” was calculated, which indicates the AUC for inhibitory receptor-positive NK cells over the AUC for inhibitory receptor-negative NK cells. The lower the figure, the larget the difference and the better the inhibition.

Priming of NK Cells Using IL-15

NK cells were incubated with recombinant IL-15 (ImmunoTool, Germany) for 2 h at 37°C to a final concentration of 100 ng/ml. Control cells were incubated at 37°C in the absence of IL-15. Following priming, cells were washed to remove unbound IL-15 after which they were incubated with antibodies to cell surface receptors and with calcium dyes. Ca2+ flux was analyzed as described in the previous sections.

Statistical Analysis

Statistical analysis was performed using GraphPad Prism 5. A paired Student's T-test was used for some experiments. For other experiments, we used a one-way Anova with multiple comparisons and Tukey's correction, as indicated in the figure legends. The degree of significance is indicated as follows: *P < 0.05, **P < 0.01, ***p < 0.001, ns, not significant.

Author Contributions

SG performed mouse experiments, analyzed data, and wrote the manuscript. PH analyzed data, wrote the manuscript, and provided funding for the study.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Acknowledgments

We thank Heinrich Schlums for help with the human NK cell experiments and Yenan Bryceson for useful input during manuscript preparation. Iyadh Douagi is gratefully acknowledged for help with FACS-based issues, in particular the ratiometric analysis method for Calcium flux. We thank the staff of animal facility at Karolinska Institutet, Huddinge campus for taking care of the experimental animals. We also thank colleagues at HERM for useful discussions in the completion of the project. This work was supported by grants to PH from the Swedish Research Council (2011-03152), the Swedish Cancer Society (2015/727), Radiumhemmets Forskingsfonder (181133), Karolinska Institutet and the Stockholm City Council (20170287).

Supplementary Material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fimmu.2018.03173/full#supplementary-material

References

1. Lam VC, Lanier LL. NK cells in host responses to viral infections. Curr Opin Immunol. (2017) 44:43–51. doi: 10.1016/j.coi.2016.11.003

PubMed Abstract | CrossRef Full Text | Google Scholar

2. Spits H, Bernink JH, Lanier L. NK cells and type 1 innate lymphoid cells: partners in host defense. Nat Immunol. (2016) 17:758–64. doi: 10.1038/ni.3482

PubMed Abstract | CrossRef Full Text | Google Scholar

3. Molgora M, Bonavita E, Ponzetta A, Riva F, Barbagallo M, Jaillon S, et al. IL-1R8 is a checkpoint in NK cells regulating anti-tumour and anti-viral activity. Nature (2017) 551:110–4. doi: 10.1038/nature24293

PubMed Abstract | CrossRef Full Text | Google Scholar

4. Screpanti V, Wallin RP, Grandien A, Ljunggren HG. Impact of FASL-induced apoptosis in the elimination of tumor cells by NK cells. Mol Immunol. (2005) 42:495–9. doi: 10.1016/j.molimm.2004.07.033

PubMed Abstract | CrossRef Full Text | Google Scholar

5. Lee J, Dieckmann NMG, Edgar JR, Griffiths GM, Siegel RM. Fas Ligand localizes to intraluminal vesicles within NK cell cytolytic granules and is enriched at the immune synapse. Immun Inflamm Dis. (2018). 6:312–21. doi: 10.1002/iid3.219

PubMed Abstract | CrossRef Full Text | Google Scholar

6. Feuerer M, Shen Y, Littman DR, Benoist C, Mathis D. How punctual ablation of regulatory T cells unleashes an autoimmune lesion within the pancreatic islets. Immunity (2009) 31:654–64. doi: 10.1016/j.immuni.2009.08.023

PubMed Abstract | CrossRef Full Text | Google Scholar

7. Hanke T, Raulet DH. Cumulative inhibition of NK cells and T cells resulting from engagement of multiple inhibitory Ly49 receptors. J Immunol (2001) 166:3002–7. doi: 10.4049/jimmunol.166.5.3002

PubMed Abstract | CrossRef Full Text | Google Scholar

8. Kaplan A, Kotzer S, Almeida CR, Kohen R, Halpert G, Salmon-Divon M, et al. Simulations of the NK cell immune synapse reveal that activation thresholds can be established by inhibitory receptors acting locally. J Immunol. (2011) 187:760–73. doi: 10.4049/jimmunol.1002208

PubMed Abstract | CrossRef Full Text | Google Scholar

9. Lanier LL. Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol. (2008) 9:495–502. doi: 10.1038/ni1581

PubMed Abstract | CrossRef Full Text | Google Scholar

10. Guethlein LA, Norman PJ, Hilton HG, Parham P. Co-evolution of MHC class I and variable NK cell receptors in placental mammals. Immunol Rev. (2015) 267:259–82. doi: 10.1111/imr.12326

PubMed Abstract | CrossRef Full Text | Google Scholar

11. Brooks AG, Posch PE, Scorzelli CJ, Borrego F, Coligan JE. NKG2A complexed with CD94 defines a novel inhibitory natural killer cell receptor. J Exp Med. (1997) 185:795–800. doi: 10.1084/jem.185.4.795

PubMed Abstract | CrossRef Full Text | Google Scholar

12. Vance RE, Kraft JR, Altman JD, Jensen PE, Raulet DH. Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b). J Exp Med. (1998) 188:1841–8. doi: 10.1084/jem.188.10.1841

PubMed Abstract | CrossRef Full Text | Google Scholar

13. Sternberg-Simon M, Brodin P, Pickman Y, Onfelt B, Karre K, Malmberg KJ, et al. Natural killer cell inhibitory receptor expression in humans and mice: a closer look. Front Immunol. (2013) 4:65. doi: 10.3389/fimmu.2013.00065

PubMed Abstract | CrossRef Full Text | Google Scholar

14. Binstadt BA, Brumbaugh KM, Dick CJ, Scharenberg AM, Williams BL, Colonna M, et al. Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation. Immunity (1996) 5:629–38. doi: 10.1016/S1074-7613(00)80276-9

PubMed Abstract | CrossRef Full Text | Google Scholar

15. Stebbins CC, Watzl C, Billadeau DD, Leibson PJ, Burshtyn DN, Long EO. Vav1 dephosphorylation by the tyrosine phosphatase SHP-1 as a mechanism for inhibition of cellular cytotoxicity. Mol Cell Biol. (2003) 23:6291–9. doi: 10.1128/MCB.23.17.6291-6299.2003

PubMed Abstract | CrossRef Full Text | Google Scholar

16. Matalon O, Fried S, Ben-Shmuel A, Pauker MH, Joseph N, Keizer D, et al. Dephosphorylation of the adaptor LAT and phospholipase C-gamma by SHP-1 inhibits natural killer cell cytotoxicity. Sci Signal (2016) 9:ra54. doi: 10.1126/scisignal.aad6182

PubMed Abstract | CrossRef Full Text | Google Scholar

17. Matalon O, Barda-Saad M. Cbl ubiquitin ligases mediate the inhibition of natural killer cell activity. Commun Integr Biol. (2016) 9:e1216739. doi: 10.1080/19420889.2016.1216739

PubMed Abstract | CrossRef Full Text | Google Scholar

18. Long EO, Kim HS, Liu D, Peterson ME, Rajagopalan S. Controlling natural killer cell responses: integration of signals for activation and inhibition. Annu Rev Immunol. (2013) 31:227–58. doi: 10.1146/annurev-immunol-020711-075005

PubMed Abstract | CrossRef Full Text | Google Scholar

19. Almeida CR, Davis DM. Segregation of HLA-C from ICAM-1 at NK cell immune synapses is controlled by its cell surface density. J Immunol. (2006) 177:6904–10. doi: 10.4049/jimmunol.177.10.6904

PubMed Abstract | CrossRef Full Text | Google Scholar

20. Bryceson YT, March ME, Ljunggren HG, Long EO. Activation, coactivation, and costimulation of resting human natural killer cells. Immunol Rev. (2006) 214:73–91. doi: 10.1111/j.1600-065X.2006.00457.x

PubMed Abstract | CrossRef Full Text | Google Scholar

21. Ganesan S, Luu TT, Chambers BJ, Meinke S, Brodin P, Vivier E, et al. The Abl-1 kinase is dispensable for NK cell inhibitory signalling and is not involved in murine NK cell education. Scand J Immunol. (2017) 86:135–42. doi: 10.1111/sji.12574

CrossRef Full Text | Google Scholar

22. Back J, Angelov GS, Mariuzza RA, Held W. The interaction with H-2D(d) in cis is associated with a conformational change in the Ly49A NK cell receptor. Front Immunol. (2011) 2:55. doi: 10.3389/fimmu.2011.00055

PubMed Abstract | CrossRef Full Text | Google Scholar

23. Held W, Mariuzza RA. Cis-trans interactions of cell surface receptors: biological roles and structural basis. Cell Mol Life Sci. (2011) 68:3469–78. doi: 10.1007/s00018-011-0798-z

PubMed Abstract | CrossRef Full Text | Google Scholar

24. Scarpellino L, Oeschger F, Guillaume P, Coudert JD, Levy F, Leclercq G, et al. Interactions of Ly49 family receptors with MHC class I ligands in trans and cis. J Immunol. (2007) 178:1277–84. doi: 10.4049/jimmunol.178.3.1277

PubMed Abstract | CrossRef Full Text | Google Scholar

25. Brodin P, Lakshmikanth T, Karre K, Hoglund P. Skewing of the NK cell repertoire by MHC class I via quantitatively controlled enrichment and contraction of specific Ly49 saubsets. J Immunol. (2012) 188:2218–26. doi: 10.4049/jimmunol.1102801

PubMed Abstract | CrossRef Full Text | Google Scholar

26. Andersson KE, Williams GS, Davis DM, Hoglund P. Quantifying the reduction in accessibility of the inhibitory NK cell receptor Ly49A caused by binding MHC class I proteins in cis. Eur J Immunol. (2007) 37:516–27. doi: 10.1002/eji.200636693

PubMed Abstract | CrossRef Full Text | Google Scholar

27. Lucas M, Schachterle W, Oberle K, Aichele P, Diefenbach A. Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity (2007) 26:503–17. doi: 10.1016/j.immuni.2007.03.006

PubMed Abstract | CrossRef Full Text | Google Scholar

28. Luu TT, Ganesan S, Wagner AK, Sarhan D, Meinke S, Garbi N, et al. Independent control of natural killer cell responsiveness and homeostasis at steady-state by CD11c+ dendritic cells. Sci Rep. (2016) 6:37996. doi: 10.1038/srep37996

PubMed Abstract | CrossRef Full Text | Google Scholar

29. Marcais A, Cherfils-Vicini J, Viant C, Degouve S, Viel S, Fenis A, et al. The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells. Nat Immunol. (2014) 15:749–57. doi: 10.1038/ni.2936

PubMed Abstract | CrossRef Full Text | Google Scholar

30. Mao Y, van Hoef V, Zhang X, Wennerberg E, Lorent J, Witt K, et al. IL-15 activates mTOR and primes stress-activated gene expression leading to prolonged antitumor capacity of NK cells. Blood (2016) 128:1475–89. doi: 10.1182/blood-2016-02-698027

PubMed Abstract | CrossRef Full Text | Google Scholar

31. Wang Y, Zhang Y, Yi P, Dong W, Nalin AP, Zhang J, et al. The IL-15-AKT-XBP1s signaling pathway contributes to effector functionsand survival in human NK cells. Nat Immunol. (2019) 20:10–7. doi: 10.1038/s41590-018-0265-1

PubMed Abstract | CrossRef Full Text | Google Scholar

32. Lopez-Verges S, Milush JM, Pandey S, York VA, Arakawa-Hoyt J, Pircher H, et al. CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset. Blood (2010) 116:3865–74. doi: 10.1182/blood-2010-04-282301

PubMed Abstract | CrossRef Full Text | Google Scholar

33. Carr WH, Pando MJ, Parham P. KIR3DL1 polymorphisms that affect NK cell inhibition by HLA-Bw4 ligand. J Immunol. (2005) 175:5222–9. doi: 10.4049/jimmunol.175.8.5222

PubMed Abstract | CrossRef Full Text | Google Scholar

34. Brodin P, Karre K, Hoglund P. NK cell education: not an on-off switch but a tunable rheostat. Trends Immunol. (2009) 30:143–9. doi: 10.1016/j.it.2009.01.006

PubMed Abstract | CrossRef Full Text | Google Scholar

35. Joncker NT, Fernandez NC, Treiner E, Vivier E, Raulet DH. NK cell responsiveness is tuned commensurate with the number of inhibitory receptors for self-MHC class I: the rheostat model. J Immunol. (2009) 182:4572–80. doi: 10.4049/jimmunol.0803900

PubMed Abstract | CrossRef Full Text | Google Scholar

36. Beziat V, Liu L, Malmberg JA, Ivarsson MA, Sohlberg E, Bjorklund AT, et al. NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs. Blood (2013) 121:2678–88 doi: 10.1182/blood-2012-10-459545

PubMed Abstract | CrossRef Full Text | Google Scholar

37. Bryceson YT, Ljunggren HG, Long EO. Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors. Blood (2009) 114:2657–66. doi: 10.1182/blood-2009-01-201632

PubMed Abstract | CrossRef Full Text

38. Kase A, Johansson MH, Olsson-Alheim MY, Karre K, Hoglund P. External and internal calibration of the MHC class I-specific receptor Ly49A on murine natural killer cells. J Immunol. (1998) 161:6133–8.

PubMed Abstract | Google Scholar

39. Back J, Chalifour A, Scarpellino L, Held W. Stable masking by H-2Dd cis ligand limits Ly49A relocalization to the site of NK cell/target cell contact. Proc Natl Acad Sci USA. (2007) 104:3978–83. doi: 10.1073/pnas.0607418104

PubMed Abstract | CrossRef Full Text | Google Scholar

40. Ljunggren HG, Karre K. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today (1990) 11:237–44. doi: 10.1016/0167-5699(90)90097-S

PubMed Abstract | CrossRef Full Text | Google Scholar

41. Johansson S, Johansson M, Rosmaraki E, Vahlne G, Mehr R, Salmon-Divon M, et al. Natural killer cell education in mice with single or multiple major histocompatibility complex class I molecules. J Exp Med. (2005) 201:1145–55. doi: 10.1084/jem.20050167

CrossRef Full Text | Google Scholar

Keywords: NK cells, MHC class I, calcium flux, Ly49, NKG2A, inhibition, IL-15, quantitative

Citation: Ganesan S and Höglund P (2019) Inhibitory Receptor Crosslinking Quantitatively Dampens Calcium Flux Induced by Activating Receptor Triggering in NK Cells. Front. Immunol. 9:3173. doi: 10.3389/fimmu.2018.03173

Received: 23 August 2018; Accepted: 24 December 2018;
Published: 14 January 2019.

Edited by:

Carsten Watzl, Leibniz Research Centre for Working Environment and Human Factors (IfADo), Germany

Reviewed by:

Mira Oshra Barda-Saad, Bar-Ilan University, Israel
Frank Momburg, German Cancer Research Center (DKFZ), Germany

Copyright © 2019 Ganesan and Höglund. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Sridharan Ganesan, sridharan.ganesan@ki.se
Petter Höglund, petter.hoglund@ki.se